Emory University as of March 31, 2018
Portfolio Holdings for Emory University
Emory University holds 46 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Berkshire Hathaway (BRK.A) | 25.0 | $35M | 117.00 | 299102.56 | |
Jd (JD) | 3.6 | $5.0M | 125k | 40.49 | |
Myovant Sciences | 2.7 | $3.8M | 176k | 21.27 | |
Beigene (BGNE) | 2.3 | $3.2M | 19k | 168.02 | |
Ascendis Pharma A S (ASND) | 2.2 | $3.1M | 47k | 65.39 | |
Blueprint Medicines (BPMC) | 2.1 | $2.9M | 32k | 91.69 | |
Kala Pharmaceuticals | 2.0 | $2.8M | 177k | 15.83 | |
Avexis | 2.0 | $2.8M | 23k | 123.57 | |
Puma Biotechnology (PBYI) | 1.9 | $2.7M | 39k | 68.04 | |
Ablynx Nv | 1.9 | $2.6M | 48k | 54.55 | |
Inflarx Nv (IFRX) | 1.9 | $2.6M | 91k | 28.84 | |
Sage Therapeutics (SAGE) | 1.9 | $2.6M | 16k | 161.05 | |
Amicus Therapeutics (FOLD) | 1.9 | $2.6M | 173k | 15.04 | |
Retrophin | 1.8 | $2.6M | 115k | 22.36 | |
Neurocrine Biosciences (NBIX) | 1.8 | $2.5M | 31k | 82.93 | |
Zogenix | 1.8 | $2.5M | 64k | 40.05 | |
Incyte Corporation (INCY) | 1.8 | $2.5M | 30k | 83.33 | |
Alnylam Pharmaceuticals (ALNY) | 1.8 | $2.5M | 21k | 119.11 | |
Seattle Genetics | 1.8 | $2.5M | 48k | 52.33 | |
Aquinox Pharmaceuticals | 1.8 | $2.5M | 179k | 14.08 | |
BioMarin Pharmaceutical (BMRN) | 1.8 | $2.5M | 31k | 81.08 | |
Genomic Health | 1.8 | $2.5M | 80k | 31.28 | |
Acceleron Pharma | 1.7 | $2.4M | 62k | 39.10 | |
Alexion Pharmaceuticals | 1.7 | $2.4M | 22k | 111.46 | |
Seagate Technology Com Stk | 1.7 | $2.4M | 41k | 58.52 | |
Corium Intl | 1.7 | $2.4M | 211k | 11.47 | |
Dicerna Pharmaceuticals | 1.7 | $2.4M | 246k | 9.56 | |
Dbv Technologies S A | 1.7 | $2.3M | 101k | 23.07 | |
La Jolla Pharmaceuticl Com Par | 1.6 | $2.3M | 77k | 29.78 | |
Biohaven Pharmaceutical Holding | 1.6 | $2.3M | 89k | 25.76 | |
Cbre Group Inc Cl A (CBRE) | 1.6 | $2.2M | 47k | 47.22 | |
Microsoft Corporation (MSFT) | 1.5 | $2.1M | 24k | 91.26 | |
Fox News | 1.5 | $2.1M | 57k | 36.37 | |
Morgan Stanley (MS) | 1.5 | $2.1M | 39k | 53.97 | |
Global Blood Therapeutics In | 1.4 | $2.0M | 42k | 48.31 | |
Trinity Industries (TRN) | 1.4 | $2.0M | 61k | 32.63 | |
Express Scripts Holding | 1.4 | $1.9M | 28k | 69.08 | |
Armstrong World Industries (AWI) | 1.4 | $1.9M | 34k | 56.31 | |
KKR & Co | 1.4 | $1.9M | 95k | 20.30 | |
Wave Life Sciences (WVE) | 1.4 | $1.9M | 48k | 40.10 | |
ACADIA Pharmaceuticals (ACAD) | 1.4 | $1.9M | 85k | 22.48 | |
Alliance Data Systems Corporation (BFH) | 1.3 | $1.8M | 8.7k | 212.88 | |
Summit Midstream Partners | 0.9 | $1.2M | 88k | 14.05 | |
Cocrystal Pharma Inc Com Par | 0.7 | $910k | 153k | 5.95 | |
Spdr S&p 500 Etf (SPY) | 0.2 | $229k | 872.00 | 262.61 | |
Amazon (AMZN) | 0.2 | $229k | 158.00 | 1449.37 |